Hemogenyx Pharmaceuticals Plc (LON: HEMO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
358.50
+15.10 (4.40%)
Dec 23, 2024, 4:35 PM BST

Hemogenyx Pharmaceuticals Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
-5.18-6.69-3.98-5.1-2.08-1.45
Upgrade
Depreciation & Amortization
0.650.650.20.130.110.09
Upgrade
Stock-Based Compensation
0.20.240.020.150.360.12
Upgrade
Other Operating Activities
0.340.530.612.09-0.130.04
Upgrade
Change in Accounts Receivable
-00-0-0.2-0.020.02
Upgrade
Change in Accounts Payable
-0.170.03-0.030.3-0.04-0.02
Upgrade
Change in Other Net Operating Assets
-0.74-0.870.27-0-
Upgrade
Operating Cash Flow
-4.91-6.11-2.91-2.63-1.8-1.2
Upgrade
Capital Expenditures
-0.1-0.12-0.43-0.64-0.17-0.01
Upgrade
Sale (Purchase) of Intangibles
----0.18--
Upgrade
Other Investing Activities
0.050.090.01-0.1200.01
Upgrade
Investing Cash Flow
-0.06-0.03-0.42-0.94-0.170
Upgrade
Short-Term Debt Issued
----0.46-
Upgrade
Total Debt Issued
----0.46-
Upgrade
Long-Term Debt Repaid
--0.64-0.11-3.22-0.04-0.04
Upgrade
Net Debt Issued (Repaid)
-0.64-0.64-0.11-3.220.42-0.04
Upgrade
Issuance of Common Stock
4.365.09-123.18-
Upgrade
Other Financing Activities
-0.03----0.39-
Upgrade
Financing Cash Flow
3.694.45-0.118.783.21-0.04
Upgrade
Foreign Exchange Rate Adjustments
-0.160.4-0.88-0.180.07-0.03
Upgrade
Miscellaneous Cash Flow Adjustments
--0.01---
Upgrade
Net Cash Flow
-1.44-1.29-4.315.031.31-1.26
Upgrade
Free Cash Flow
-5.02-6.22-3.34-3.26-1.97-1.21
Upgrade
Free Cash Flow Per Share
-1.64-2.20-1.36-1.69-1.90-1.34
Upgrade
Levered Free Cash Flow
-2.73-3.81-3.35-3.11-1.1-0.86
Upgrade
Unlevered Free Cash Flow
-2.54-3.61-3.35-2.24-1.08-0.84
Upgrade
Change in Net Working Capital
0.770.91-0.320.010.03-0.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.